In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials (PDQ®)

  • First Published: 12/4/2007
  • Last Modified: 5/24/2012

Page Options

  • Print This Page
  • Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Phase III Randomized Study of Depot Octreotide Acetate and Interferon alfa-2b Versus Depot Octreotide Acetate and Bevacizumab in Patients With Unresectable Metastatic or Locally Advanced, High-Risk Neuroendocrine Carcinoid Tumor

Alternate Title
Basic Trial Information
Objectives
Entry Criteria
Expected Enrollment
Outcomes
Outline
Trial Contact Information
Related Information
Registry Information

Alternate Title

Octreotide and Interferon alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
Phase IIITreatmentActiveNot specifiedNCISWOG-S0518
S0518, NCT00569127

Special Category: CTSU trial, NCI Web site featured trial

Objectives

  1. To compare central review-based progression-free survival (PFS) in poor prognosis carcinoid patients treated with either depot octreotide acetate plus bevacizumab or depot octreotide acetate plus interferon.
  2. To compare overall survival, time to treatment failure, and traditionally reported progression-free survival of poor prognosis carcinoid patients treated with either depot octreotide acetate plus bevacizumab or depot octreotide acetate plus interferon.
  3. To compare objective response (confirmed and unconfirmed complete and partial response) in poor prognosis carcinoid patients treated with either depot octreotide acetate plus bevacizumab or depot octreotide acetate plus interferon.
  4. To compare the toxicity profile of these two regimens in these patients.
  5. To assess the prognostic and predictive value of VEGF expression in relation to PFS and treatment effect.
  6. To compare response of 5HIAA, chromogranin A, and neurospecific enolase among patients with elevated levels at baseline between patients treated with octreotide acetate plus interferon versus octreotide acetate plus bevacizumab.
  7. To assess and compare the prognostic and predictive value of the combination of IN-111 pentetreotide somatostatin-receptor scintigraphy (SRS) and CT scan vs. CT scan alone in relation to PFS.
  8. To assess and compare the prognostic and predictive value of the combination of SRS and CT scan vs CT scan alone in relation to overall survival and time to treatment failure.

Entry Criteria

Disease Characteristics:

Inclusion criteria:

  • Diagnosis of unresectable metastatic or locally advanced, low- or intermediate-grade neuroendocrine carcinoma, including the following subtypes:
    • Carcinoid tumor, low-grade or well differentiated neuroendocrine carcinoma
    • Atypical carcinoid tumor, intermediate-grade or moderately differentiated neuroendocrine carcinoma

  • High-risk disease as defined by at least one of the following:
    • Progressive disease
    • Refractory carcinoid syndrome while receiving octreotide acetate (i.e., defined by > 2 flushing episodes/day or > 4 bowel movements/day)
    • Atypical histology and more than 6 lesions
    • Metastatic colorectal carcinoid tumor
      • Patients with metastatic cecal or appendiceal carcinoid tumor are not eligible unless they fit other mentioned high-risk features
    • Metastatic gastric carcinoid tumor

  • Measurable disease

  • Patients with poorly differentiated neuroendocrine carcinoma, high-grade neuroendocrine carcinoma, adenocarcinoid tumor, or goblet cell carcinoid tumor are not eligible

Exclusion criteria:

  • Osseous metastasis as only site of disease

  • Medullary thyroid carcinoma or islet cell carcinoma

  • History of primary brain tumor or metastatic cancer to the brain

Prior/Concurrent Therapy:

  • Recovered from all prior therapy
  • At least 28 days since and no more than 1 prior regimen of cytotoxic chemotherapy
  • At least 28 days since prior hepatic artery embolization provided there is residual measurable disease
    • Chemoembolization is considered as 1 prior chemotherapy regimen
  • No prior interferon, bevacizumab, or any other therapy targeting VEGF or VEGF receptors (e.g., SU11248, PTK/ZK, sorafenib tosylate, or pazopanib hydrochloride)
  • Prior therapy targeting c-kit, abl, PDGFR, mTOR, and somatostatin receptors allowed
  • At least 28 days since prior radiotherapy
    • Target lesions must have show disease progression if therapy included peptide receptor radiotherapy
  • At least 1 week since prior minor surgery
  • At least 4 weeks since prior major surgery
  • At least 21 days since prior octreotide acetate therapy
  • Concurrent full-dose anticoagulation (warfarin or low molecular weight heparin) allowed provided the following criteria are met:
    • In-range INR (e.g., between 2 and 3) on a stable dose of oral anticoagulant or on a stable dose of low molecular weight heparin
    • No active bleeding or pathological condition that carries a high risk of bleeding (e.g., varices)
  • No concurrent interferon to control carcinoid syndrome for patients receiving bevacizumab
    • Other supportive care medication (e.g., short acting octreotide acetate) allowed
  • No other concurrent chemotherapy, immunotherapy, radiotherapy, hepatic artery embolization, hepatic artery chemoembolization, radiofrequency ablation, or other tumor ablative procedure
  • No other investigational or commercial agents

Patient Characteristics:

Inclusion criteria:

  • Zubrod performance status 0-2
  • Platelet count > 100,000/mm³
  • ANC > 1,500/mm³
  • Hemoglobin > 8 g/dL
  • Serum bilirubin < 1.5 times upper limit of normal (ULN)
  • SGOT and SGPT ≤ 2.5 times ULN
  • Serum creatinine < 1.5 mg/dL
  • 24-hour urine protein < 1,000 mg if urine protein:creatinine ratio > 0.5
  • PT and PTT ≤ 1.1 times ULN
  • History of hypertension must be well controlled (i.e., blood pressure < 150/90 mm Hg) on a stable regimen of antihypertensive therapy
  • Not pregnant or nursing
  • Fertile patients must use effective barrier method contraception during and for 6 months after completion of study treatment

Exclusion criteria:

  • History or evidence of clinically significant peripheral vascular disease (e.g., non-healing peripheral ulcers or claudication)
  • Abdominal fistula, gastrointestinal perforation, or intra-abdominal abscess within the past 28 days
  • Bleeding diathesis or coagulopathy that results in spontaneous bleeding (in the absence of trauma) requiring red blood cell transfusion within the past 5 years
  • Serious (i.e., requiring active medical therapy with medication or medical device under the supervision of a physician) non-healing wound, ulcer, or bone fracture
  • Recent history (i.e., within the past 6 months) of any of the following arterial thromboembolic events:
    • Transient ischemic attack
    • Cerebrovascular accident
    • Unstable angina
    • Myocardial infarction
    • New York Heart Association class II or higher congestive heart failure
  • Hemoglobinopathies (e.g., Thalassemia) or any other cause of hemolytic anemia
  • Pregnant or nursing
  • Any other prior malignancy within the past 5 years except for adequately treated basal cell or squamous cell skin cancer, or other adequately treated in situ cancer
  • Any immunologically mediated disease, including any of the following:
    • Inflammatory bowel disease (Crohn disease, ulcerative colitis)
    • Rheumatoid arthritis
    • Idiopathic thrombocytopenia purpura
    • Systemic lupus erythematosus
    • Autoimmune hemolytic anemia
    • Scleroderma
    • Severe psoriasis
  • Any serious intercurrent infections or nonmalignant medical illnesses that are uncontrolled or whose control may be jeopardized by the complications of this treatment
  • Psychiatric disorders rendering patient incapable of complying with the requirements of the protocol

Expected Enrollment

400

Outcomes

Primary Outcome(s)

Progression-free survival

Secondary Outcome(s)

Overall survival
Time to treatment failure
Progression-free survival (reported traditionally)
Objective response
Toxicity

Outline

This is a multicenter study. Patients are stratified according to site of disease (small bowel vs cecum vs appendix vs other site), disease progression after initial diagnosis (yes or no), histologic grade (low vs intermediate [atypical]), and prior octreotide acetate therapy within the past 2 months (yes vs no). Patients are randomized to 1 of 2 treatment arms.

  • Arm I (octreotide acetate and bevacizumab): Patients receive depot octreotide acetate intramuscularly (IM) and bevacizumab IV over 30-90 minutes on day 1.

  • Arm II (octreotide acetate and interferon alfa-2b): Patients receive octreotide acetate IM as in arm I on day 1 and interferon alfa-2b subcutaneously (SC) on days 1, 3, 5, 8, 10, 12, 15, 17, and 19.

Treatment in both arms repeats every 21 days in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed every 2-6 months for up to 3 years.

Trial Contact Information

Trial Lead Organizations

Southwest Oncology Group

James Yao, MD, Protocol chair
Ph: 713-792-2828; 800-392-1611

Trial Sites

U.S.A.
Alabama
  Mobile
 Providence Cancer Center at Providence Hospital
 Thaddeus Beeker
Ph: 251-633-1890
Alaska
  Fairbanks
 Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
 Craig Nichols, MD
Ph: 503-494-6346
Arkansas
  Bentonville
 Highlands Oncology Group - Springdale
 Joseph Beck, MD, FACP
Ph: 479-587-1700
  Ft. Smith
 Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
 John Wells, MD
Ph: 479-484-4700
  Little Rock
 Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
 Clinical Trial Office - Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Ph: 501-686-8274
California
  Berkeley
 Alta Bates Summit Comprehensive Cancer Center
 Clinical Trials Office - Alta Bates Summit Comprehensive Cancer Center
Ph: 510-204-3428
  Burlingame
 Peninsula Medical Center
 David Irwin, MD
Ph: 510-204-1591
  Los Angeles
 Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
 Edward Wolin
Ph: 310-423-3277
 USC/Norris Comprehensive Cancer Center and Hospital
 Clinical Trials Office - USC/Norris Comprehensive Cancer Center and Hospital
Ph: 323-865-0451
  Novato
 Sutter Health - Western Division Cancer Research Group
 David Irwin, MD
Ph: 510-204-1591
  Pismo Beach
 David Palchak, MD
Ph: 805-773-7127
  San Diego
 Kaiser Permanente Medical Office -Vandever Medical Office
 Han Koh
Ph: 619-528-2596
  San Francisco
 California Pacific Medical Center - California Campus
 David Irwin, MD
Ph: 510-204-1591
  Stanford
 Stanford Cancer Center
 Clinical Trials Office - Stanford Cancer Center
Ph: 650-498-7061
  Email: cctoffice@stanford.edu
  Vallejo
 Sutter Solano Medical Center
 David Irwin, MD
Ph: 510-204-1591
Colorado
  Alamosa
 San Luis Valley Regional Medical Center
 Stephen Leong
  Aurora
 Aurora Presbyterian Hospital
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
 University of Colorado Cancer Center at UC Health Sciences Center
 Clinical Trials Office - University of Colorado Cancer Center
Ph: 720-848-0650
  Boulder
 Boulder Community Hospital
 Clinical Trials Office - Boulder Community Hospital
Ph: 303-938-5253
  Colorado Springs
 Penrose Cancer Center at Penrose Hospital
 Clinical Trials Office - Penrose Cancer Center
Ph: 719-776-5275
  Denver
 CCOP - Colorado Cancer Research Program
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
 Porter Adventist Hospital
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
 Presbyterian - St. Luke's Medical Center
 Clinical Trials Office - Presbyterian - St. Luke's Medical Center
Ph: 303-839-6000
 Rose Medical Center
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
 St. Anthony Central Hospital
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
 St. Joseph Hospital
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
 Veterans Affairs Medical Center - Denver
 Stephen Leong
Ph: 303-399-8020
888-336-8262
  Edwards
 Shaw Regional Cancer Center
 Stephen Leong
Ph: 970-569-7429
  Englewood
 Swedish Medical Center
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Fort Collins
 Front Range Cancer Specialists
 Robert Marschke, Jr.
Ph: 970-212-7600
 Poudre Valley Hospital
 Clinical Trials Office - Poudre Valley Hospital
Ph: 970-495-8226
  Glenwood Springs
 Valley View Hospital Cancer Center
 Stephen Leong
Ph: 970-945-6535
  Grand Junction
 St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
 Stephen Leong
Ph: 970-244-7500
  Greeley
 North Colorado Medical Center
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Littleton
 Littleton Adventist Hospital
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Lone Tree
 Sky Ridge Medical Center
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Longmont
 Hope Cancer Care Center at Longmont United Hospital
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Loveland
 McKee Medical Center
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Montrose
 Montrose Memorial Hospital Cancer Center
 Clinical Trials Office - Montrose Memorial Hospital Cancer Center
Ph: 670-240-7267
  Parker
 Parker Adventist Hospital
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Pueblo
 St. Mary - Corwin Regional Medical Center
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Thornton
 North Suburban Medical Center
 Eduardo Pajon, MD
Ph: 303-399-8020ext2261
  Wheat Ridge
 Exempla Lutheran Medical Center
 Clinical Trials Office - Exempla Lutheran Medical Center
Ph: 303-403-3605
Connecticut
  Hartford
 Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
 Philip Stella, MD
Ph: 734-712-1000
  Manchester
 Manchester Memorial Hospital
 Stephen Grund
Ph: 860-646-1222
  Norwich
 Eastern Connecticut Hematology and Oncology Associates
 Dennis Slater, MD
Ph: 860-886-8362
Delaware
  Lewes
 Tunnell Cancer Center at Beebe Medical Center
 Clinical Trials Office - Tunnell Cancer Center
Ph: 302-645-3171
  Newark
 CCOP - Christiana Care Health Services
 Clinical Trial Office - CCOP - Christiana Care Health Services
Ph: 302-623-4450
District of Columbia
  Washington
 Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
 Clinical Trials Office - Lombardi Comprehensive Cancer Center
Ph: 202-444-0381
Florida
  Jacksonville
 Baptist Cancer Institute - Jacksonville
 Clinical Trials Office - Baptist Cancer Institute - Jacksonville
Ph: 904-202-7051
 Mayo Clinic - Jacksonville
 Clinical Trials Office - All Mayo Clinic Locations
Ph: 507-538-7623
  Tampa
 H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
 Clinical Trials Office - H. Lee Moffitt Cancer Center and Reseach Institute
Ph: 800-456-7121
  Email: canceranswers@moffitt.org
Georgia
  Gainesville
 Northeast Georgia Medical Center
 Charles Nash, MD
Ph: 770-297-5700
  Savannah
 Nancy N. and J. C. Lewis Cancer and Research Pavilion at St. Joseph's/Candler
 O. George Negrea, MD
Ph: 912-692-2000
Idaho
  Boise
 Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
 Clinical Trials Office - Saint Alphonsus Cancer Care Center
Ph: 208-367-7954
Illinois
  Alton
 Saint Anthony's Hospital at Saint Anthony's Health Center
 Bethany Sleckman, MD
Ph: 314-251-7057
  Bloomington
 St. Joseph Medical Center
 Nguyet Le-Lindqwister
Ph: 309-662-3311
  Bloomington%
 Illinois CancerCare - Bloomington
 Nguyet Le-Lindqwister
Ph: 309-662-2102
  Canton
 Graham Hospital
 Nguyet Le-Lindqwister
Ph: 309-647-5240
 Illinois CancerCare - Canton
 Nguyet Le-Lindqwister
Ph: 309-647-5240
  Carthage
 Illinois CancerCare - Carthage
 Nguyet Le-Lindqwister
Ph: 217-357-6877
 Memorial Hospital
 Nguyet Le-Lindqwister
Ph: 217-357-3131
  Chicago
 Hematology and Oncology Associates
 Clinical Trails Office - Hematology and Oncology Associates
Ph: 312-695-1301
 Robert H. Lurie Comprehensive Cancer Center at Northwestern University
 Clinical Trials Office - Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Ph: 312-695-1301
  Email: cancer@northwestern.edu
  Decatur
 Decatur Memorial Hospital Cancer Care Institute
 Clinical Trials Office - Decatur Memorial Hospital Cancer Care Institute
Ph: 217-876-4750
  Eureka
 Eureka Community Hospital
 Nguyet Le-Lindqwister
Ph: 309-467-2371
 Illinois CancerCare - Eureka
 Nguyet Le-Lindqwister
Ph: 309-467-2371
  Galesburg
 Galesburg Clinic, PC
 Nguyet Le-Lindqwister
Ph: 309-344-1000
 Illinois CancerCare - Galesburg
 Nguyet Le-Lindqwister
Ph: 309-344-9269
  Havana
 Illinois CancerCare - Havana
 Nguyet Le-Lindqwister
Ph: 309-543-8557
 Mason District Hospital
 Nguyet Le-Lindqwister
Ph: 309-543-4431
  Highland Park
 Kellogg Cancer Care Center
 Al Benson, MD, FACP
Ph: 312-695-6180
  Kankakee
 Provena St. Mary's Regional Cancer Center - Kankakee
 Al Benson, MD, FACP
Ph: 312-695-6180
  Kewanee
 Illinois CancerCare - Kewanee Clinic
 Nguyet Le-Lindqwister
Ph: 309-852-0598
  La Grange
 La Grange Memorial Hospital
 Clinical Trials Office - La Grange Memorial Hospital
Ph: 630-856-7526
  Libertyville
 North Shore Oncology and Hematology Associates, Limited - Libertyville
 Al Benson, MD, FACP
Ph: 312-695-6180
  Macomb
 Illinois CancerCare - Macomb
 Nguyet Le-Lindqwister
Ph: 309-833-3503
 McDonough District Hospital
 Nguyet Le-Lindqwister
Ph: 309-833-4101
  Moline
 Costas Constantinou, MD
Ph: 563-359-9876
 Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
 Costas Constantinou, MD
Ph: 563-359-9876
  Monmouth
 Illinois CancerCare - Monmouth
 Nguyet Le-Lindqwister
Ph: 309-734-3141
 OSF Holy Family Medical Center
 Nguyet Le-Lindqwister
Ph: 309-734-3141
  Mount Vernon
 Good Samaritan Regional Health Center
 Bethany Sleckman, MD
Ph: 314-251-7057
  Niles
 Cancer Care and Hematology Specialists of Chicagoland - Niles
 Al Benson, MD, FACP
Ph: 312-695-6180
  Normal
 BroMenn Regional Medical Center
 Nguyet Le-Lindqwister
Ph: 309-454-1400
 Community Cancer Center
 Nguyet Le-Lindqwister
Ph: 309-451-8500
 Illinois CancerCare - Community Cancer Center
 Nguyet Le-Lindqwister
Ph: 309-662-2102
  Ottawa
 Community Hospital of Ottawa
 Nguyet Le-Lindqwister
Ph: 815-433-3100
 Oncology Hematology Associates of Central Illinois, PC - Ottawa
 Nguyet Le-Lindqwister
Ph: 815-431-9270
  Pekin
 Cancer Treatment Center at Pekin Hospital
 Nguyet Le-Lindqwister
Ph: 309-353-0512
 Illinois CancerCare - Pekin
 Nguyet Le-Lindqwister
Ph: 309-353-0214
  Peoria
 CCOP - Illinois Oncology Research Association
 Nguyet Le-Lindqwister
Ph: 309-243-3605
800-793-2262
 Methodist Medical Center of Illinois
 Clinical Trials Office - Methodist Medical Center of Illinois
Ph: 309-243-3000
 Oncology Hematology Associates of Central Illinois, PC - Peoria
 Nguyet Le-Lindqwister
Ph: 309-243-3000
 OSF St. Francis Medical Center
 Nguyet Le-Lindqwister
Ph: 309-655-2000
 Proctor Hospital
 Nguyet Le-Lindqwister
Ph: 309-691-1000
  Peru
 Illinois CancerCare - Peru
 Nguyet Le-Lindqwister
Ph: 815-780-3185
 Illinois Valley Community Hospital
 Nguyet Le-Lindqwister
Ph: 815-223-3000
  Princeton
 Illinois CancerCare - Princeton
 Nguyet Le-Lindqwister
Ph: 815-875-3010
 Perry Memorial Hospital
 Nguyet Le-Lindqwister
Ph: 815-875-2811
  Rockford
 Swedish-American Regional Cancer Center
 Clinical Trials Office - Swedish-American Regional Cancer Center
Ph: 815-489-4413
  Skokie
 Hematology Oncology Associates - Skokie
 Al Benson, MD, FACP
Ph: 312-695-6180
  Spring Valley
 Illinois CancerCare - Spring Valley
 Nguyet Le-Lindqwister
Ph: 815-664-1487
  Springfield
 Regional Cancer Center at Memorial Medical Center
 Clinical Trials Office - Regional Cancer Center at Memorial Medical Center
Ph: 217-788-4233
Indiana
  Elkhart
 Elkhart Clinic, LLC
 Robin Zon, MD
Ph: 574-296-6536
 Elkhart General Hospital
 Robin Zon, MD
Ph: 574-296-6536
 Michiana Hematology-Oncology, PC - Elkhart
 Robin Zon, MD
Ph: 574-296-6536
  Kokomo
 Howard Community Hospital
 Robin Zon, MD
Ph: 574-296-6536
  La Porte
 Center for Cancer Therapy at LaPorte Hospital and Health Services
 Robin Zon, MD
Ph: 574-296-6536
  Mishawaka
 Michiana Hematology-Oncology, PC - South Bend
 Robin Zon, MD
Ph: 574-296-6536
 Saint Joseph Regional Medical Center
 Robin Zon, MD
Ph: 574-296-6536
  Plymouth
 Michiana Hematology Oncology PC - Plymouth
 Robin Zon, MD
Ph: 574-296-6536
  South Bend
 CCOP - Northern Indiana CR Consortium
 Robin Zon, MD
Ph: 574-296-6536
 Memorial Hospital of South Bend
 Clinical Trials Office - Memorial Hospital of South Bend
Ph: 800-284-7370
 Michiana Hematology-Oncology, PC - South Bend
 Robin Zon, MD
Ph: 574-296-6536
  Westville
 Michiana Hematology Oncology PC - La Porte
 Robin Zon, MD
Ph: 574-296-6536
Iowa
  Ames
 McFarland Clinic, PC
 Clinical Trials Office - McFarland Clinic, PC
Ph: 515-239-2621
  Bettendorf
 Costas Constantinou, MD
Ph: 563-359-9876
 Hematology Oncology Associates of the Quad Cities
 Shobha Chitneni, MD, MBBS
Ph: 563-355-7733
  Cedar Rapids
 Cedar Rapids Oncology Associates
 Clinical Trials Office - Cedar Rapids Oncology Associates
Ph: 319-363-2690
 Mercy Regional Cancer Center at Mercy Medical Center
 Deborah Wilbur
Ph: 319-398-6011
  Davenport
 Genesis Regional Cancer Center at Genesis Medical Center
 George Kovach, MD
Ph: 563-421-1960
  Sioux City
 Mercy Medical Center - Sioux City
 Donald Wender, MD, PhD
Ph: 712-252-0088
 Siouxland Hematology-Oncology Associates, LLP
 Donald Wender, MD, PhD
Ph: 712-252-0088
 St. Luke's Regional Medical Center
 Donald Wender, MD, PhD
Ph: 712-252-0088
Kansas
  Great Bend
 St. Rose Ambulatory and Surgery Center
 Peter VanVeldhuizen, MD
Ph: 816-861-4700ext.56775
  Hays
 Hays Medical Center
 Peter VanVeldhuizen, MD
Ph: 816-861-4700ext.56775
  Hutchinson
 Hutchinson Hospital Corporation
 Peter VanVeldhuizen, MD
Ph: 816-861-4700ext.56775
  Kansas City
 Kansas City Cancer Centers - West
 Peter VanVeldhuizen, MD
Ph: 816-861-4700ext.56775
 Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
 Clinical Trials Office - Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Ph: 913-588-4709
  Overland Park
 Kansas City Cancer Centers - Southwest
 Peter VanVeldhuizen, MD
Ph: 816-861-4700ext.56775
  Pittsburg
 Mount Carmel Regional Cancer Center
 Peter VanVeldhuizen, MD
Ph: 816-861-4700ext.56775
  Salina
 Tammy Walker Cancer Center at Salina Regional Health Center
 Peter VanVeldhuizen, MD
Ph: 816-861-4700ext.56775
  Topeka
 Cotton-O'Neil Cancer Center
 Clinical Trials Office - Cotton-O'Neil Cancer Center
Ph: 785-270-4963
 St. Francis Comprehensive Cancer Center
 Peter VanVeldhuizen, MD
Ph: 816-861-4700ext.56775
Louisiana
  Alexandria
 Tulane Cancer Center Office of Clinical Research
 Clinical Trials Office - Tulane Cancer Center
Ph: 504-988-6121
  Baton Rouge
 Mary Bird Perkins Cancer Center - Baton Rouge
 Robert Veith
Ph: 225-767-0847
 Ochsner Health Center - Bluebonnet
 Jyotsna Fuloria
Ph: 225-761-5200
  Covington
 Ochsner Health Center - Covington
 Jyotsna Fuloria
Ph: 985-875-2828
866-624-7637
  New Orleans
 CCOP - Ochsner
 Jyotsna Fuloria
Ph: 504-842-3910
 MBCCOP - LSU Health Sciences Center
 Robert Veith
Ph: 504-568-5151
 Medical Center of Louisiana - New Orleans
 Robert Veith
Ph: 504-903-2311
 New Orleans Cancer Institute at Memorial Medical Center
 Jyotsna Fuloria
Ph: 504-894-2700
 Ochsner Cancer Institute at Ochsner Clinic Foundation
 Jyotsna Fuloria
Ph: 504-842-4360
888-624-7637
Maryland
  Elkton MD
 Union Hospital of Cecil County
 Stephen Grubbs, MD
Ph: 302-366-1200
Massachusetts
  Boston
 Boston University Cancer Research Center
 Clinical Trials Office - Boston University Cancer Research Center
Ph: 617-638-8265
 Dana-Farber/Brigham and Women's Cancer Center
 Clinical Trials Office
Ph: 617-724-5200
 Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
 Matthew Kulke
Ph: 617-632-3474
866-790-4500
 Massachusetts General Hospital
 Clinical Trials Office - Massachusetts General Hospital
Ph: 877-726-5130
Michigan
  Adrian
 Hickman Cancer Center at Bixby Medical Center
 Clinical Trials Office - Hickman Cancer Center at Bixby Medical Center
Ph: 517-265-0116
  Ann Arbor
 CCOP - Michigan Cancer Research Consortium
 Philip Stella, MD
Ph: 734-712-1000
 Saint Joseph Mercy Cancer Center
 Philip Stella, MD
Ph: 734-712-1000
 University of Michigan Comprehensive Cancer Center
 Clinical Trials Office - University of Michigan Comprehensive Cancer Center
Ph: 800-865-1125
  Dearborn
 Oakwood Cancer Center at Oakwood Hospital and Medical Center
 Clinical Trials Office - Oakwood Cancer Center at Oakwood Hospital and Medical Center
Ph: 313-593-8090
  Escanaba
 Green Bay Oncology, Limited - Escanaba
 Thomas Saphner, MD, FACP
Ph: 920-884-3135
  Flint
 Genesys Hurley Cancer Institute
 Clinical Trials Office - Genesys Hurley Cancer Institute
Ph: 810-762-8057
 Hurley Medical Center
 Clinical Trials Office - Hurley Medical Center
Ph: 810-762-8057
  Grand Blanc
 Genesys Regional Medical Center
 Philip Stella, MD
Ph: 734-712-1000
  Grosse Pointe Woods
 Van Elslander Cancer Center at St. John Hospital and Medical Center
 Clincial Trials Office - Van Elslander Cancer Center at St. John Hospital and Medical Center
Ph: 313-343-3166
  Iron Mountain
 Dickinson County Healthcare System
 Thomas Saphner, MD, FACP
Ph: 920-884-3135
  Jackson
 Foote Memorial Hospital
 Philip Stella, MD
Ph: 734-712-1000
  Kalamazoo
 Borgess Medical Center
 Raymond Lord, MD
Ph: 269-373-7458
 Bronson Methodist Hospital
 Raymond Lord, MD
Ph: 269-373-7458
 West Michigan Cancer Center
 Clinical Trials Office - West Michigan Cancer Center
Ph: 269-373-7458
  Lansing
 Sparrow Regional Cancer Center
 Clinical Trials Office - Sparrow Regional Cancer Center
Ph: 517-364-2890
  Livonia
 St. Mary Mercy Hospital
 Philip Stella, MD
Ph: 734-712-1000
  Monroe
 Community Cancer Center of Monroe
 Rex Mowat
Ph: 734-242-7902
 Mercy Memorial Hospital - Monroe
 Rex Mowat
Ph: 734-240-8400
  Pontiac
 St. Joseph Mercy Oakland
 Philip Stella, MD
Ph: 734-712-1000
  Port Huron
 Mercy Regional Cancer Center at Mercy Hospital
 Philip Stella, MD
Ph: 734-712-1000
  Saginaw
 Seton Cancer Institute at Saint Mary's - Saginaw
 Clinical Trials Office - Seton Cancer Institute - Saginaw
Ph: 989-776-8411
  Saint Joseph
 Lakeside Cancer Specialists, PLLC
 Robin Zon, MD
Ph: 574-296-6536
  St. Joseph
 Lakeland Regional Cancer Care Center - St. Joseph
 Robin Zon, MD
Ph: 574-296-6536
  Warren
 St. John Macomb Hospital
 Philip Stella, MD
Ph: 734-712-1000
Minnesota
  Alexandria
 Donald Jurgens
  Burnsville
 Fairview Ridges Hospital
 Patrick Flynn, MD
Ph: 612-863-8585
  Coon Rapids
 Mercy and Unity Cancer Center at Mercy Hospital
 Patrick Flynn, MD
Ph: 612-863-8585
  Edina
 Fairview Southdale Hospital
 Clinical Trials Office - Fairview Southdale Hospital
Ph: 612-625-3650
  Fridley
 Mercy and Unity Cancer Center at Unity Hospital
 Patrick Flynn, MD
Ph: 612-863-8585
  Hutchinson
 Hutchinson Area Health Care
 Patrick Flynn, MD
Ph: 612-863-8585
  Maplewood
 HealthEast Cancer Care at St. John's Hospital
 Patrick Flynn, MD
Ph: 612-863-8585
 Minnesota Oncology - Maplewood
 Patrick Flynn, MD
Ph: 612-863-8585
  Minneapolis
 Hennepin County Medical Center - Minneapolis
 Clinical Trials Office - Hennepin County Medical Center - Minneapolis
Ph: 612-873-5911
 Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
 Clinical Trials Office - Virginia Piper Cancer Institute
Ph: 612-863-5654
  New Ulm
 New Ulm Medical Center
 Patrick Flynn, MD
Ph: 612-863-8585
  Robbinsdale
 Humphrey Cancer Center at North Memorial Outpatient Center
 Clinical Trials Office - Humphrey Cancer Center at North Memorial Outpatient Center
Ph: 763-520-1893
  Rochester
 Mayo Clinic Cancer Center
 Clinical Trials Office - All Mayo Clinic Locations
Ph: 507-538-7623
  Saint Cloud
 CentraCare Clinic - River Campus
 Donald Jurgens
Ph: 320-252-5131
 Coborn Cancer Center
 Donald Jurgens
Ph: 320-229-4907
877-229-4907
  Saint Louis Park
 CCOP - Metro-Minnesota
 Patrick Flynn, MD
Ph: 612-863-8585
 Park Nicollet Cancer Center
 Patrick Flynn, MD
Ph: 612-863-8585
  Saint Paul
 United Hospital
 Patrick Flynn, MD
Ph: 612-863-8585
  Shakopee
 St. Francis Cancer Center at St. Francis Medical Center
 Patrick Flynn, MD
Ph: 612-863-8585
  St. Paul
 Regions Hospital Cancer Care Center
 Clinical Trials Office - Regions Hospital Cancer Care Center
Ph: 651-254-1517
  Stillwater
 Lakeview Hospital
 Patrick Flynn, MD
Ph: 612-863-8585
  Waconia
 Ridgeview Medical Center
 Patrick Flynn, MD
Ph: 612-863-8585
  Willmar
 Willmar Cancer Center at Rice Memorial Hospital
 Patrick Flynn, MD
Ph: 612-863-8585
  Woodbury
 Minnesota Oncology - Woodbury
 Patrick Flynn, MD
Ph: 612-863-8585
Mississippi
  Jackson
 University of Mississippi Cancer Clinic
 Louis Puneky
Ph: 601-984-5590
Missouri
  Cape Girardeau
 Saint Francis Medical Center
 Bethany Sleckman, MD
Ph: 314-251-7057
 Southeast Cancer Center
 Alan Lyss, MD
Ph: 314-996-5514
  Jefferson City
 Goldschmidt Cancer Center
 Alan Lyss, MD
Ph: 314-996-5514
  Kansas City
 Kansas City Cancer Centers - North
 Peter VanVeldhuizen, MD
Ph: 816-861-4700ext.56775
 Kansas City Cancer Centers - South
 Peter VanVeldhuizen, MD
Ph: 816-861-4700ext.56775
 Truman Medical Center - Hospital Hill
 Peter VanVeldhuizen, MD
Ph: 816-861-4700ext.56775
  Lee's Summit
 Kansas City Cancer Centers - East
 Peter VanVeldhuizen, MD
Ph: 816-861-4700ext.56775
  Rolla
 Mercy Clinic Cancer and Hematology - Rolla
 Robert Carolla
Ph: 573-458-6379
 Phelps County Regional Medical Center
 Robert Carolla
Ph: 573-458-8899
  Saint Louis
 CCOP - St. Louis-Cape Girardeau
 Bethany Sleckman, MD
Ph: 314-251-7057
 Comprehensive Cancer Care, PC
 Alan Lyss, MD
Ph: 314-996-5514
 David C. Pratt Cancer Center at St. John's Mercy
 Clinical Trials Office - David C. Pratt Cancer Center at St. John's Mercy
Ph: 314-251-6770
 Midwest Hematology Oncology Group, Incorporated
 Bethany Sleckman, MD
Ph: 314-251-7057
 Missouri Baptist Cancer Center
 Alan Lyss, MD
Ph: 314-996-5514
 Saint Louis University Cancer Center
 Clinical Trials Office - Saint Louis University Cancer Center
Ph: 314-977-4440
  Springfield
 CCOP - Cancer Research for the Ozarks
 Robert Carolla
Ph: 417-269-4520
 Hulston Cancer Center at Cox Medical Center South
 Robert Carolla
Ph: 417-269-5257
 St. John's Regional Health Center
 Robert Carolla
Ph: 417-820-2000
Montana
  Billings
 Billings Clinic - Downtown
 Clinical Trials Office - Billings Clinic - Downtown
Ph: 800-996-2663
  Email: research@billingsclinic.org
 CCOP - Montana Cancer Consortium
 Benjamin Marchello, MD
Ph: 406-238-6290
 Hematology-Oncology Centers of the Northern Rockies - Billings
 Benjamin Marchello, MD
Ph: 406-238-6290
 St. Vincent Healthcare Cancer Care Services
 Benjamin Marchello, MD
Ph: 406-238-6290
  Bozeman
 Bozeman Deaconess Cancer Center
 Benjamin Marchello, MD
Ph: 406-238-6290
  Butte
 St. James Healthcare Cancer Care
 Benjamin Marchello, MD
Ph: 406-238-6290
  Great Falls
 Big Sky Oncology
 Clinical Trial Office - Big Sky Oncology
Ph: 406-731-8217
 Great Falls Clinic - Main Facility
 Benjamin Marchello, MD
Ph: 406-238-6290
 Sletten Cancer Institute at Benefis Healthcare
 Grant Harrer, MD, FACP, CCTI
Ph: 406-731-8100
  Havre
 Northern Montana Hospital
 Benjamin Marchello, MD
Ph: 406-238-6290
  Helena
 St. Peter's Hospital
 Benjamin Marchello, MD
Ph: 406-238-6290
  Kalispell
 Glacier Oncology, PLLC
 Benjamin Marchello, MD
Ph: 406-238-6290
 Kalispell Medical Oncology at KRMC
 Benjamin Marchello, MD
Ph: 406-238-6290
 Kalispell Regional Medical Center
 Benjamin Marchello, MD
Ph: 406-238-6290
  Missoula
 Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
 Clinical Trials Office - Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
Ph: 406-329-7029
 Montana Cancer Specialists at Montana Cancer Center
 Clinical Trials Office - Montana Cancer Specialists at Montana Cancer Center
Ph: 406-238-6962
Nebraska
  Grand Island
 Saint Francis Cancer Treatment Center at Saint Francis Memorial Health Center
 Jean Grem, MD
Ph: 402-559-6210
  Kearney
 Good Samaritan Cancer Center at Good Samaritan Hospital
 Clinical Trials Office - Good Samaritan Cancer Center at Good Samaritan Hospital
Ph: 308-865-7963
  Lincoln
 Cancer Resource Center - Lincoln
 Gamini Soori, MD, FACP, FRCP, MBA
Ph: 402-393-3110
  North Platte
 Callahan Cancer Center at Great Plains Regional Medical Center
 Clinical Trials Office - Callahan Cancer Center at Great Plains Regional Medical Center
Ph: 308-696-7864
  Omaha
 Alegant Health Cancer Center at Bergan Mercy Medical Center
 Clinical Trials Office - Alegant Health Cancer Center at Bergen Mercy Medical Center
Ph: 402-398-6060
 CCOP - Missouri Valley Cancer Consortium
 Gamini Soori, MD, FACP, FRCP, MBA
Ph: 402-393-3110
 Creighton University Medical Center
 Clinical Trials Office - Creighton University Medical Center
Ph: 402-280-4100
 Immanuel Medical Center
 Gamini Soori, MD, FACP, FRCP, MBA
Ph: 402-393-3110
 Lakeside Hospital
 Gamini Soori, MD, FACP, FRCP, MBA
Ph: 402-393-3110
 Methodist Estabrook Cancer Center
 Robert Langdon, MD
Ph: 402-399-8762
 UNMC Eppley Cancer Center at the University of Nebraska Medical Center
 Clinical Trials Office - UNMC Eppley Cancer Center at the University of Nebraska Medical Center
Ph: 800-999-5465
Nevada
  Las Vegas
 CCOP - Nevada Cancer Research Foundation
 John Ellerton, MD, CM
Ph: 702-384-0013
 University Medical Center of Southern Nevada
 John Ellerton, MD, CM
Ph: 702-384-0013
New Jersey
  Flemington
 Hunterdon Regional Cancer Center at Hunterdon Medical Center
 Kenneth Blankstein, MD
Ph: 908-788-6100
  Voorhees
 Cancer Institute of New Jersey at Cooper - Voorhees
 Clinical Trials Office - Cancer Institute of New Jersey at Cooper University Hospital - Voorhees
Ph: 856-325-6757
New Mexico
  Albuquerque
 University of New Mexico Cancer Center
 Clinical Trials Office - University of New Mexico Cancer Center
Ph: 505-272-6972
  Las Cruces
 University of New Mexico Cancer Center - South
 Yehuda Patt
Ph: 505-521-1554
New York
  Buffalo
 Roswell Park Cancer Institute
 Clinical Trials Office - Roswell Park Cancer Institute
Ph: 877-275-7724
  Middletown
 Tucker Center for Cancer Care at Orange Regional Medical Center
 Clinical Trials Office - Tucker Center for Cancer Care at Orange Regional Medical Center
Ph: 845-342-7609
North Carolina
  Charlotte
 Blumenthal Cancer Center at Carolinas Medical Center
 Clinical Trials Office - Blumenthal Cancer Center at Carolinas Medical Center
Ph: 704-355-2884
  Goldsboro
 Wayne Memorial Hospital, Incorporated
 James Atkins, MD
Ph: 919-580-0000
  Kinston
 Kinston Medical Specialists
 Peter Watson, MD
Ph: 252-559-2200ext.201
  Statesville
 Iredell Memorial Hospital
 Ruby Grimm, MD
Ph: 704-873-2219
North Dakota
  Bismarck
 Bismarck Cancer Center
 Edward Wos, DO
Ph: 701-323-5741
 Medcenter One Hospital Cancer Care Center
 Edward Wos, DO
Ph: 701-323-5741
 Mid Dakota Clinic, PC
 Clinical Trials Office - Mid Dakota Clinic, PC
Ph: 701-530-6950
 St. Alexius Medical Center Cancer Center
 Clinical Trials Office - St. Alexius Medical Center Cancer Center
Ph: 701-530-6950
Ohio
  Akron
 McDowell Cancer Center at Akron General Medical Center
 Esther Rehmus, MD
Ph: 330-344-6505
 Summa Center for Cancer Care at Akron City Hospital
 Clinical Trials Office - Akron City Hospital
Ph: 330-375-6101
  Barberton
 Barberton Citizens Hospital
 Jennifer Payne
Ph: 330-745-1611
  Bowling Green
 Wood County Oncology Center
 Rex Mowat
Ph: 419-352-9498
  Canton
 Aultman Cancer Center at Aultman Hospital
 Clinical Trials Office - Aultman Cancer Center at Aultman Hospital
Ph: 330-363-6891
  Chillicothe
 Adena Regional Medical Center
 Clinical Trials Office - Adena Regional Medical Center
Ph: 877-779-7585
  Cleveland
 MetroHealth Cancer Care Center at MetroHealth Medical Center
 Bruce Averbook, MD, FACS
Ph: 216-778-4795
  Columbus
 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
 Ohio State University Cancer Clinical Trial Matching Service
Ph: 866-627-7616
  Email: osu@emergingmed.com
 CCOP - Columbus
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
 Doctors Hospital at Ohio Health
 Clinical Trials Office - Doctors Hospital at Ohio Health
Ph: 614-566-3275
 Grant Medical Center Cancer Care
 Clinical Trials Office - Grant Medical Center Cancer Care
Ph: 614-566-4475
 Mount Carmel Health - West Hospital
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
 Riverside Methodist Hospital Cancer Care
 Clinical Trials Office - Riverside Methodist Hospital Cancer Care
Ph: 614-566-4475
 Zangmeister Center
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
  Delaware
 Grady Memorial Hospital
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
  Elyria
 Community Cancer Center
 Rex Mowat
Ph: 440-324-0400
 Hematology Oncology Center
 Rex Mowat
Ph: 440-324-0401
  Lancaster
 Fairfield Medical Center
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
  Lima
 Lima Memorial Hospital
 Rex Mowat
Ph: 419-228-3335
 St. Rita's Medical Center
 Clinical Trials Office - St. Rita's Medical Center
Ph: 419-226-9617
  Marietta
 Strecker Cancer Center at Marietta Memorial Hospital
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
  Maumee
 Northwest Ohio Oncology Center
 Rex Mowat
Ph: 419-891-5600
 Rex Mowat
Ph: 419-891-5600
  Mount Vernon
 Knox Community Hospital
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
  Newark
 Licking Memorial Cancer Care Program at Licking Memorial Hospital
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
  Norwalk
 Fisher-Titus Medical Center
 Rex Mowat
Ph: 419-668-8101
800-589-3862
  Oregon
 St. Charles Mercy Hospital
 Rex Mowat
Ph: 419-696-7200
 Toledo Clinic - Oregon
 Rex Mowat
Ph: 419-691-4235
  Portsmouth
 Southern Ohio Medical Center Cancer Center
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
  Sandusky
 North Coast Cancer Care, Incorporated
 Rex Mowat
Ph: 419-626-9090
  Springfield
 Community Hospital of Springfield and Clark County
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
  Sylvania
 Flower Hospital Cancer Center
 Clinical Trials Office - Flower Hospital Cancer Center
Ph: 419-824-1842
  Tiffin
 Mercy Hospital of Tiffin
 Rex Mowat
Ph: 419-447-3130
  Toledo
 CCOP - Toledo Community Hospital
 Rex Mowat
Ph: 419-843-6147
 Medical University of Ohio Cancer Center
 Clinical Trials Office - Medical University of Ohio Cancer Center
Ph: 419-383-6583
 St. Anne Mercy Hospital
 Rex Mowat
Ph: 419-407-2663
 St. Vincent Mercy Medical Center
 Rex Mowat
Ph: 419-251-4515
 Toledo Clinic, Incorporated - Main Clinic
 Rex Mowat
Ph: 419-479-5605
 Toledo Hospital
 Clinical Trials Office - Toledo Hospital
Ph: 419-824-1842
  Wauseon
 Fulton County Health Center
 Clinical Trials Office - Fulton County Health Center
Ph: 419-330-2708
  Westerville
 Mount Carmel St. Ann's Cancer Center
 J. Philip Kuebler, MD, PhD
Ph: 614-442-3130
  Zanesville
 Genesis - Good Samaritan Hospital
 Clinical Trials Office - Genesis - Good Samaritan Hospital
Ph: 740-454-5232
Oklahoma
  Lawton
 Cancer Centers of Southwest Oklahoma, LLC - Lawton
 Nadim Nimeh, MD
Ph: 580-536-2121ext.113
Oregon
  Clackamas
 Clackamas Radiation Oncology Center
 Janet Ruzich
Ph: 503-513-3300
  Coos Bay
 Bay Area Hospital
 Bret Cook, MD
Ph: 541-267-5151
  Milwaukie
 Providence Milwaukie Hospital
 Janet Ruzich
Ph: 503-513-8300
  Newberg
 Providence Newberg Medical Center
 Janet Ruzich
Ph: 503-537-1555
  Oregon City
 Willamette Falls Hospital
 Janet Ruzich
Ph: 503-650-6758
  Portland
 CCOP - Columbia River Oncology Program
 Janet Ruzich
Ph: 503-216-6260
 Kaiser Permanente Health Care - Portland
 Nagendra Tirumali, MD
Ph: 503-331-6500
 Providence Cancer Center at Providence Portland Medical Center
 Clinical Trials Office - Providence Cancer Center at Providence Portland Medical Center
Ph: 503-215-6412
 Providence St. Vincent Medical Center
 Clinical Trials Office - Providence St. Vincent Medical Center
Ph: 503-215-6412
Pennsylvania
  Allentown
 Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
 Eliot Friedman, MD
Ph: 610-402-0512
  Danville
 Geisinger Cancer Institute at Geisinger Health
 Clinical Trials Office - Geisinger Cancer Institute
Ph: 570-271-5251
  East Stroudsburg
 Dale and Frances Hughes Cancer Center at Pocono Medical Center
 Rita Axelrod, MD
Ph: 215-955-8874
  Hazleton
 Geisinger Hazleton Cancer Center
 Maged Khalil
Ph: 570-459-2901
  Philadelphia
 Abramson Cancer Center of the University of Pennsylvania
 Clinical Trials Office - Abramson Cancer Center of the University of Pennsylvania
Ph: 800-474-9892
  Sayre
 Guthrie Cancer Center at Guthrie Clinic Sayre
 Clinical Trials Office - Guthrie Cancer Center at Guthrie Clinic Sayre
Ph: 800-836-0388
  Scranton
 Hematology and Oncology Associates of Northeastern Pennsylvania
 Martin Hyzinski, MD
Ph: 570-558-3020
 Mercy Hospital Cancer Center - Scranton
 Martin Hyzinski, MD
Ph: 570-558-3020
  State College
 Geisinger Medical Group - Scenery Park
 Maged Khalil
Ph: 814-231-4560
  West Grove
 Jennersville Regional Hospital
 Clinical Trials Office - Jennersville Regional Hospital
Ph: 610-869-1396
  Wilkes-Barre
 Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
 Clinical Trials Office - Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
Ph: 570-271-5251
South Carolina
  Easley
 Cancer Centers of the Carolinas - Easley
 Clinical Trials Office - Cancer Centers of the Carolinas
Ph: 864-241-6251
  Greenville
 Cancer Centers of the Carolinas - Faris Road
 Jeffrey Giguere, MD, FACP
Ph: 864-987-7000
 Cancer Centers of the Carolinas - Grove Commons
 Clinical Trials Office - Cancer Centers of the Carolinas
Ph: 864-241-6251
 CCOP - Greenville
 Jeffrey Giguere, MD, FACP
Ph: 864-987-7000
 Greenville Hospital Cancer Center
 Clinical Trials Office - Greenville Hospital Cancer Center
Ph: 864-241-6251
  Greenwood
 Self Regional Cancer Center at Self Regional Medical Center
 Jeffrey Giguere, MD, FACP
Ph: 864-987-7000
  Greer
 Cancer Centers of the Carolinas - Greer Medical Oncology
 Jeffrey Giguere, MD, FACP
Ph: 864-987-7000
  Seneca
 Cancer Centers of the Carolinas - Seneca
 Jeffrey Giguere, MD, FACP
Ph: 864-987-7000
  Spartanburg
 Cancer Centers of the Carolinas - Spartanburg
 Jeffrey Giguere, MD, FACP
Ph: 864-987-7000
South Dakota
  Sioux Falls
 Avera Cancer Institute
 Addison Tolentino
Ph: 605-322-3000
 Addison Tolentino
Ph: 605-322-3000
 Medical X-Ray Center, PC
 Miroslaw Mazurczak
Ph: 605-336-0515
800-473-0271
 Sanford Cancer Center at Sanford USD Medical Center
 Clinical Trials Office - Sanford Cancer Center
Ph: 605-328-1367
Tennessee
  Chattanooga
 Erlanger Cancer Center at Erlanger Hospital - Baroness
 Clinical Trials Office - Erlanger Cancer Center
Ph: 423-778-6947
  Knoxville
 Center for Biomedical Research
 Tracy Dobbs, MD
Ph: 865-632-5122
  Nashville
 Vanderbilt-Ingram Cancer Center
 Clinical Trials Office - Vanderbilt-Ingram Cancer Center
Ph: 800-811-8480
Texas
  Amarillo
 Harrington Cancer Center
 Clinical Trials Officec - Harrington Cancer Center
Ph: 806-359-4673
  Email: ryokubaitis@harringtoncc.org
  Houston
 M. D. Anderson Cancer Center at University of Texas
 Clinical Trials Office - M. D. Anderson Cancer Center at the University of Texas
Ph: 713-792-3245
Virginia
  Danville
 Danville Regional Medical Center
 Clinical Trials Office - Danville Regional Medical Center
Ph: 434-799-3753
  Fredericksburg
 Fredericksburg Oncology, Incorporated
 Rex Mowat
Ph: 540-368-0500
Washington
  Anacortes
 Island Hospital Cancer Care Center at Island Hospital
 Saul Rivkin, MD
Ph: 206-386-2441
  Bellingham
 St. Joseph Cancer Center
 Saul Rivkin, MD
Ph: 206-386-2441
  Bremerton
 Olympic Hematology and Oncology
 Saul Rivkin, MD
Ph: 206-386-2441
  Burien
 Highline Medical Center Cancer Center
 Saul Rivkin, MD
Ph: 206-386-2441
  Issaquah
 Swedish Medical Center - Issaquah Campus
 Saul Rivkin, MD
Ph: 206-386-2441
  Kennewick
 Columbia Basin Hematology
 Saul Rivkin, MD
Ph: 206-386-2441
  Kirkland
 Cascade Cancer Center at Evergreen Hospital Medical Center
 Craig Nichols, MD
Ph: 503-494-6346
  Mount Vernon
 Skagit Valley Hospital Cancer Care Center
 Saul Rivkin, MD
Ph: 206-386-2441
  Poulsbo
 Harrison Poulsbo Hematology and Onocology
 Saul Rivkin, MD
Ph: 206-386-2441
  Seattle
 CCOP - Virginia Mason Research Center
 Craig Nichols, MD
Ph: 503-494-6346
 Fred Hutchinson Cancer Research Center
 Saul Rivkin, MD
Ph: 206-386-2441
 Group Health Central Hospital
 Clinical Trials Office - Group Health Central Hospital
Ph: 206-287-2900
 Harborview Medical Center
 Saul Rivkin, MD
Ph: 206-386-2441
 Minor and James Medical, PLLC
 Saul Rivkin, MD
Ph: 206-386-2441
 Pacific Medical Center
 Craig Nichols, MD
Ph: 503-494-6346
 Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
 Saul Rivkin, MD
Ph: 206-386-2441
 University Cancer Center at University of Washington Medical Center
 Saul Rivkin, MD
Ph: 206-386-2441
 Virginia Mason Medical Center
 Craig Nichols, MD
Ph: 503-494-6346
  Sedro-Woolley
 North Puget Oncology at United General Hospital
 Saul Rivkin, MD
Ph: 206-386-2441
  Spokane
 Cancer Care Northwest - Spokane South
 Clinical Trials Office - Cancer Care Northwest - Spokane South
Ph: 509-228-1083
 Evergreen Hematology and Oncology, PS
 Saul Rivkin, MD
Ph: 206-386-2441
  Vancouver
 Northwest Cancer Specialists at Vancouver Cancer Center
 Janet Ruzich
Ph: 360-944-9889
 Southwest Washington Medical Center Cancer Center
 Janet Ruzich
Ph: 360-514-2174
  Wenatchee
 Wenatchee Valley Medical Center
 Clinical Trials Office - Wenatchee Valley Medical Center
Ph: 509-665-5800
West Virginia
  Charleston
 West Virginia University Health Sciences Center - Charleston
 Steven Jubelirer, MD
Ph: 304-388-8380
  Princeton
 Princeton Community Hospital
 Rowena Gonzales-Chambers, MD
Ph: 304-425-1453
Wisconsin
  Chippewa Falls
 Marshfield Clinic - Chippewa Center
 Adedayo Onitilo
Ph: 715-726-4200
800-334-4535
  Eau Claire
 Marshfield Clinic Cancer Care at Regional Cancer Center
 Adedayo Onitilo
Ph: 715-387-5426
  Green Bay
 Green Bay Oncology, Limited at St. Mary's Hospital
 Thomas Saphner, MD, FACP
Ph: 920-884-3135
 Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
 Thomas Saphner, MD, FACP
Ph: 920-884-3135
 St. Mary's Hospital Medical Center - Green Bay
 Thomas Saphner, MD, FACP
Ph: 920-884-3135
 St. Vincent Hospital Regional Cancer Center
 Clinical Trials Office - St. Vincent Hospital Regional Cancer Center
Ph: 920-433-8889
  Manitowoc
 Holy Family Memorial Medical Center Cancer Care Center
 Clinical Trials Office - Holy Family Memorial Medical Center Cancer Care Center
Ph: 920-320-2749
  Marinette
 Bay Area Cancer Care Center at Bay Area Medical Center
 Thomas Saphner, MD, FACP
Ph: 920-884-3135
  Marshfield
 Marshfield Clinic - Marshfield Center
 Clinical Trials Office - Marshfield Clinic - Marshfield Center
Ph: 800-782-1581 ext. 94457
  Minocqua
 Marshfield Clinic - Lakeland Center
 Adedayo Onitilo
Ph: 715-358-1000
800-347-0673
  Oconto Falls
 Green Bay Oncology, Limited - Oconto Falls
 Thomas Saphner, MD, FACP
Ph: 920-884-3135
  Rhinelander
 Ministry Medical Group at Saint Mary's Hospital
 Adedayo Onitilo
Ph: 715-361-4700
800-866-8673
  Rice Lake
 Marshfield Clinic - Indianhead Center
 Adedayo Onitilo
Ph: 715-236-8100
  Sheboygan
 St. Nicholas Hospital
 Thomas Saphner, MD, FACP
Ph: 920-884-3135
  Stevens Point
 Marshfield Clinic at Saint Michael's Hospital
 Adedayo Onitilo
Ph: 715-295-1900
800-782-8581
 Saint Michael's Hospital Cancer Center
 Adedayo Onitilo
Ph: 715-346-5000
800-472-9449
  Sturgeon Bay
 Green Bay Oncology, Limited - Sturgeon Bay
 Thomas Saphner, MD, FACP
Ph: 920-884-3135
  Weston
 Marshfield Clinic - Weston Center
 Adedayo Onitilo
Ph: 715-393-1000
888-782-8581
  Wisconsin Rapids
 Marshfield Clinic - Wisconsin Rapids Center
 Adedayo Onitilo
Ph: 715-424-8600
Wyoming
  Sheridan
 Welch Cancer Center at Sheridan Memorial Hospital
 Benjamin Marchello, MD
Ph: 406-238-6290

Related Information

Featured trial article

Registry Information
Official Title Phase III Prospective Randomized Comparison of Depot Octreotide Plus Interferon Alpha Versus Depot Octreotide Plus Bevacizumab (NSC #704865) in Advanced, Poor Prognosis Carcinoid Patients
Trial Start Date 2007-12-01
Trial Completion Date 2012-01-31 (estimated)
Registered in ClinicalTrials.gov NCT00569127
Date Submitted to PDQ 2007-11-21
Information Last Verified 2012-05-24
NCI Grant/Contract Number CA32102

Note: The purpose of most clinical trials listed in this database is to test new cancer treatments, or new methods of diagnosing, screening, or preventing cancer. Because all potentially harmful side effects are not known before a trial is conducted, dose and schedule modifications may be required for participants if they develop side effects from the treatment or test. The therapy or test described in this clinical trial is intended for use by clinical oncologists in carefully structured settings, and may not prove to be more effective than standard treatment. A responsible investigator associated with this clinical trial should be consulted before using this protocol.

Back to TopBack to Top